Company / R&D Expense
iSpecimen Inc. R&D Expense History
FY2021-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$1.6M
FY2024
5-year range
$319.2K / $1.6M
FY2021-FY2024
Trend
+9.9%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D Expense has increased for 3 consecutive years, from $319,235 in FY2021 to $2M in FY2024.
Based on SEC 10-K filings.
$2M in FY2024 with a 3-year CAGR of +71.8%.
Improved from $879,243 to $2M over the past 2 years.
R&D Expense over time
Growth rates
- 3-Year CAGR
- +71.8%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- iSpecimen Inc.'s r&d expense has grown for 3 consecutive years.
- 3-year CAGR of +71.8%, indicating consistent growth.
- In FY2024, r&d expense increased 9.9% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.90 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $1.6M | +9.9% |
| FY2023 | $1.5M | +67.6% |
| FY2022 | $879.2K | +175.4% |
| FY2021 | $319.2K | - |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026